Clinical Trial Update: Experiment to Assess Preferences for Novel Hormonal Therapy and Androgen-deprivation Therapy in Prostate Cancer Patients

View source ↗

Summary

A completed clinical trial update reports on patient preferences between a novel hormonal therapy and standard androgen-deprivation therapy in prostate cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Androgen deprivation therapy (Androgen deprivation therapy)
• Novel Hormonal Therapy

Snippet

Sponsor: Astellas Pharma Global Development, Inc. | Conditions: Prostate Cancer | Status: COMPLETED